Cargando…
Chemoresponse after non-curative gastrectomy for M1 gastric cancer
BACKGROUND: M1 gastric cancer has a poor oncologic outcome with a median survival of less than 1 year despite aggressive chemotherapy. Recent trials include chemotherapy combined non-curative gastrectomy. This study evaluated the chemoresponse after non-curative gastrectomy in M1 gastric cancer and...
Autores principales: | Shin, Hyun Beak, Lee, Seung Hyoung, Son, Young Gil, Ryu, Seung Wan, Sohn, Soo Sang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327950/ https://www.ncbi.nlm.nih.gov/pubmed/25634223 http://dx.doi.org/10.1186/s12957-015-0447-3 |
Ejemplares similares
-
Successful treatment of invasive gastric mucormycosis in a patient with alcoholic liver cirrhosis: A case report
por: LEE, SEUNG HYOUNG, et al.
Publicado: (2014) -
Characteristics of gastric cancer recurrence five or more years after curative gastrectomy
por: Shin, Chang-Hyun, et al.
Publicado: (2016) -
Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?
por: Shin, Hyun Beak, et al.
Publicado: (2017) -
Local complications are related to poor long-term outcome in patients undergoing curative gastrectomy for advanced gastric cancer
por: Ha, Tae Sun, et al.
Publicado: (2022) -
Safe Discharge Criteria After Curative Gastrectomy for Gastric Cancer
por: Guner, Ali, et al.
Publicado: (2022)